Skip to main content
PMC home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1997 Nov;4(6):719–722. doi: 10.1128/cdli.4.6.719-722.1997

Fecal lactoferrin, interleukin-1beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis.

T S Steiner 1, C A Flores 1, T T Pizarro 1, R L Guerrant 1
PMCID: PMC170647  PMID: 9384296

Abstract

Twenty-two patients with Clostridium difficile colitis as determined by positive enzyme immunoassay for toxin A were evaluated for fecal inflammatory markers and their relationship to the severity of illness. Fourteen of 22 specimens were positive for fecal lactoferrin (FLF), with titers from 1:50 to 1:800. Nine of 10 stools tested had ratios of interleukin-1beta (IL-1beta) to IL-1 receptor antagonist (IL-1ra) of >0.01. Seventeen of 22 specimens also had elevated IL-8 concentrations, and 12 of 14 had elevated IL-1beta concentrations. A review of the 18 available patient records revealed that fecal IL-8 concentrations, IL-1beta/IL-1ra ratios, and FLF titers were significantly higher in patients with moderate to severe disease than in patients with mild disease. These findings suggest that the proinflammatory effects of C. difficile may directly influence clinical characteristics of human disease.

Full Text

The Full Text of this article is available as a PDF (162.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anand A., Bashey B., Mir T., Glatt A. E. Epidemiology, clinical manifestations, and outcome of Clostridium difficile-associated diarrhea. Am J Gastroenterol. 1994 Apr;89(4):519–523. [PubMed] [Google Scholar]
  2. Boland G. W., Lee M. J., Cats A. M., Ferraro M. J., Matthia A. R., Mueller P. R. Clostridium difficile colitis: correlation of CT findings with severity of clinical disease. Clin Radiol. 1995 Mar;50(3):153–156. doi: 10.1016/s0009-9260(05)83045-4. [DOI] [PubMed] [Google Scholar]
  3. Braegger C. P., Nicholls S., Murch S. H., Stephens S., MacDonald T. T. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet. 1992 Jan 11;339(8785):89–91. doi: 10.1016/0140-6736(92)90999-j. [DOI] [PubMed] [Google Scholar]
  4. Burakoff R., Zhao L., Celifarco A. J., Rose K. L., Donovan V., Pothoulakis C., Percy W. H. Effects of purified Clostridium difficile toxin A on rabbit distal colon. Gastroenterology. 1995 Aug;109(2):348–354. doi: 10.1016/0016-5085(95)90320-8. [DOI] [PubMed] [Google Scholar]
  5. Casini-Raggi V., Kam L., Chong Y. J., Fiocchi C., Pizarro T. T., Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol. 1995 Mar 1;154(5):2434–2440. [PubMed] [Google Scholar]
  6. Dillon S. T., Rubin E. J., Yakubovich M., Pothoulakis C., LaMont J. T., Feig L. A., Gilbert R. J. Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B. Infect Immun. 1995 Apr;63(4):1421–1426. doi: 10.1128/iai.63.4.1421-1426.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dinarello C. A. Biologic basis for interleukin-1 in disease. Blood. 1996 Mar 15;87(6):2095–2147. [PubMed] [Google Scholar]
  8. Edmond M. B., Ober J. F., Weinbaum D. L., Pfaller M. A., Hwang T., Sanford M. D., Wenzel R. P. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis. 1995 May;20(5):1126–1133. doi: 10.1093/clinids/20.5.1126. [DOI] [PubMed] [Google Scholar]
  9. Fonteles M., Fang G., Thielman N. M., Yotseff P. S., Guerrant R. L. Role of platelet activating factor in the inflammatory and secretory effects of Clostridium difficile toxin A. J Lipid Mediat Cell Signal. 1995 Mar;11(2):133–143. doi: 10.1016/0929-7855(94)00033-9. [DOI] [PubMed] [Google Scholar]
  10. Just I., Selzer J., Wilm M., von Eichel-Streiber C., Mann M., Aktories K. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature. 1995 Jun 8;375(6531):500–503. doi: 10.1038/375500a0. [DOI] [PubMed] [Google Scholar]
  11. Just I., Wilm M., Selzer J., Rex G., von Eichel-Streiber C., Mann M., Aktories K. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem. 1995 Jun 9;270(23):13932–13936. doi: 10.1074/jbc.270.23.13932. [DOI] [PubMed] [Google Scholar]
  12. Kelly C. P., Becker S., Linevsky J. K., Joshi M. A., O'Keane J. C., Dickey B. F., LaMont J. T., Pothoulakis C. Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. J Clin Invest. 1994 Mar;93(3):1257–1265. doi: 10.1172/JCI117080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. MacDonald T. T., Murch S. H., Nicholls S. W., Breese E. J. Diarrhoeal disease: current concepts and future challenges. Intestinal cytokines in inflammatory bowel disease and invasive diarrhoea. Trans R Soc Trop Med Hyg. 1993 Dec;87 (Suppl 3):23–26. doi: 10.1016/0035-9203(93)90532-u. [DOI] [PubMed] [Google Scholar]
  14. Manabe Y. C., Vinetz J. M., Moore R. D., Merz C., Charache P., Bartlett J. G. Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann Intern Med. 1995 Dec 1;123(11):835–840. doi: 10.7326/0003-4819-123-11-199512010-00004. [DOI] [PubMed] [Google Scholar]
  15. Marx C. E., Morris A., Wilson M. L., Reller L. B. Fecal leukocytes in stool specimens submitted for Clostridium difficile toxin assay. Diagn Microbiol Infect Dis. 1993 May-Jun;16(4):313–315. doi: 10.1016/0732-8893(93)90081-h. [DOI] [PubMed] [Google Scholar]
  16. Moreno F., Grota P., Crisp C., Magnon K., Melcher G. P., Jorgensen J. H., Patterson J. E. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis. 1995 Nov;21(5):1234–1237. doi: 10.1093/clinids/21.5.1234. [DOI] [PubMed] [Google Scholar]
  17. Munoz C., Baqar S., van de Verg L., Thupari J., Goldblum S., Olson J. G., Taylor D. N., Heresi G. P., Murphy J. R. Characteristics of Shigella sonnei infection of volunteers: signs, symptoms, immune responses, changes in selected cytokines and acute-phase substances. Am J Trop Med Hyg. 1995 Jul;53(1):47–54. [PubMed] [Google Scholar]
  18. Pothoulakis C., Castagliuolo I., LaMont J. T., Jaffer A., O'Keane J. C., Snider R. M., Leeman S. E. CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin. Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):947–951. doi: 10.1073/pnas.91.3.947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Raqib R., Lindberg A. A., Wretlind B., Bardhan P. K., Andersson U., Andersson J. Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect Immun. 1995 Jan;63(1):289–296. doi: 10.1128/iai.63.1.289-296.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Raqib R., Wretlind B., Andersson J., Lindberg A. A. Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma. J Infect Dis. 1995 Feb;171(2):376–384. doi: 10.1093/infdis/171.2.376. [DOI] [PubMed] [Google Scholar]
  21. Silletti R. P., Lee G., Ailey E. Role of stool screening tests in diagnosis of inflammatory bacterial enteritis and in selection of specimens likely to yield invasive enteric pathogens. J Clin Microbiol. 1996 May;34(5):1161–1165. doi: 10.1128/jcm.34.5.1161-1165.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Teasley D. G., Gerding D. N., Olson M. M., Peterson L. R., Gebhard R. L., Schwartz M. J., Lee J. T., Jr Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet. 1983 Nov 5;2(8358):1043–1046. doi: 10.1016/s0140-6736(83)91036-x. [DOI] [PubMed] [Google Scholar]
  23. Yong W. H., Mattia A. R., Ferraro M. J. Comparison of fecal lactoferrin latex agglutination assay and methylene blue microscopy for detection of fecal leukocytes in Clostridium difficile-associated disease. J Clin Microbiol. 1994 May;32(5):1360–1361. doi: 10.1128/jcm.32.5.1360-1361.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES